ZYME Stock Analysis: Buy, Sell, or Hold?
ZYME - Zymeworks Inc.
$23.88
0.62 (2.67%)
▲
5d:
+2.67%
30d:
-4.9%
90d:
-0.58%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ZYME Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ZYME trading at deep discount. Market pricing in -16.9% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ZYME trading at deep discount. Market pricing in -16.9% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.63
Based on -20.9% avg growth
INTRINSIC VALUE TODAY
$2.88
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZYME is currently trading at $23.88, which is considered fair relative to its 30-day fair value range of $23.17 to $25.02. From a valuation perspective, the stock is trading at a discount (Forward PE: 34.9) compared to its historical average (60.9). Remarkably, the market is currently pricing in an annual earnings decline of 16.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ZYME is in a uptrend. Immediate support is located at $22.14, while resistance sits at $24.65.
Market Sentiment: ZYME has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.23 (+64.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZYME is in a uptrend. Immediate support is located at $22.14, while resistance sits at $24.65.
Market Sentiment: ZYME has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.23 (+64.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$23.17 -
$25.02
Company Quality Score
63/100
(BUY)
Options IV Signal
47th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 47th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.3% below Wall St target ($39.23)
Trading Range Analysis
30-Day Trading Range
$23.17 -
$25.02
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$2.99
(12.5%)
Support & Resistance Levels
Support Level
$22.14
Resistance Level
$24.65
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
34.94
Wall Street Target
$39.23
(+64.3%)
Revenue Growth (YoY)
-91.1%
Profit Margin
-126.3%
Valuation Discount vs History
-16.9% cheaper
PE vs Historical
34.9 vs 60.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.9%
(market-implied from PE analysis)
1-Year Target
$21.49
(-10%)
2-Year Target
$19.34
(-19%)
3-Year Target
$17.41
(-27%)
3-Yr Target (if PE normalizes)
(PE: 35→61)
$30.34
(+27%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 34.9, Growth: -45.9%)
$17.41
(+-27%)
Base:
(SPY PE: 21.8, Growth: -45.9%)
$10.85
(-55%)
Bear:
(PE: 18.5, Growth: -45.9%)
$9.22
(-61%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 34.9 to 60.9
Stabilization Target:
$41.63
(+74.3%)
PE Expansion Potential:
+74.3%
Share & Embed Analysis
Last updated: June 24, 2026 6:25 AM ET
Data refreshes hourly during market hours. Next update: 7:25 AM
Data refreshes hourly during market hours. Next update: 7:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZYME showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeffrey T L Smith
SELL
9310 shares
2026-01-12
Kenneth Galbraith
SELL
30424 shares
2026-01-12
Mark Hollywood
SELL
6120 shares
2026-01-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 63 BUY |
Advanced ZYME Option Strategies
Professional options setups generated by AI based on today's ZYME price and gamma walls.
